The Union Cycliste Internationale (UCI) announces today that Ms Denise Betsema was sanctioned with a six-month ineligibility period following an anti-doping rule violation (ADRV), for the presence of an anabolic androgenic steroid in samples collected during the Telenet UCI Cyclo-cross World Cup round in Hoogerheide (the Netherlands), on 27 January 2019, and the Telenet Superprestige Noordzeecross Middelkeker (Belgium), on 16 February 2019.
These tests had been planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI responsible for defining and implementing cycling’s anti-doping strategy.
The athlete was provisionally suspended on April 5, 2019, and her period of ineligibility ended on October 4, 2019.
The case was resolved by acceptance of consequences in accordance with the World Anti-Doping Code and the UCI Anti-Doping Regulations. The resolution is subject to appeal by the National Anti-Doping Organisation of the Netherlands and the World Anti-Doping Agency.
The UCI will not make any further comments.